Hepatitis B Vaccine Injection

Product/Composition Hepatitis B Vaccine Injection
Strength 10ml
Form Injection
Production Capacity 1 Million Injection /Month
Package Insert/Leaflet Available upon request

Hepatitis B Vaccine Injection

  • Type: Preventive vaccine

  • Composition: Contains Hepatitis B surface antigen (HBsAg) produced using recombinant DNA technology.

  • Form: Sterile suspension for intramuscular (IM) injection

How It Works

  • When injected, the HBsAg stimulates the immune system to produce antibodies against hepatitis B virus (HBV).

  • These antibodies protect against future HBV infection by neutralizing the virus if exposed.

  • Provides active immunity that can last for decades after full vaccination.

Common Uses

  • Routine immunization of infants, children, and adults

  • Pre-exposure prophylaxis for individuals at risk, such as:

    • Healthcare workers

    • People with chronic liver disease

    • People with multiple sexual partners

    • Travelers to high-risk areas

  • Post-exposure prophylaxis (along with hepatitis B immunoglobulin) after exposure to HBV

Dosing Schedule (General)

  • Typically given as a series of 3 injections:

    1. Dose 1: At chosen start date

    2. Dose 2: 1 month after first dose

    3. Dose 3: 6 months after first dose

  • Some accelerated schedules are available for urgent protection (e.g., for travelers).

Advantages

  • Highly effective (over 90–95% protection in healthy individuals)

  • Long-lasting immunity (often lifelong after full series)

  • Helps prevent chronic hepatitis B, cirrhosis, and liver cancer

Possible Side Effects

Mild/Temporary:

  • Pain, redness, or swelling at injection site

  • Mild fever

  • Fatigue or headache

Rare but Serious:

  • Severe allergic reaction (anaphylaxis – very rare)

Precautions

  • Should not be given to people with a severe allergic reaction to a previous dose or to yeast (vaccine is yeast-derived)

  • Safe for infants, children, adults, and pregnant women (when indicated)

  • Immunocompromised individuals may require post-vaccination antibody testing to confirm protection